Skip to content

Adaptive Biotechnologies ADPT Proceeds From Contributed Capital

Proceeds From Contributed Capital at other companies

Amentum Holdings logo
Amentum HoldingsAMTM
$0-100%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.48M
Harley-Davidson logo
Harley-DavidsonHOG
$11.65M
Tango Therapeutics logo
Tango TherapeuticsTNGX
$172.25K
Twenty One Capital
 logo
Twenty One Capital XXI
$1M
GHC
Graham HoldingsGHC
$190K+25.8%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromContributedCapital.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's proceeds from contributed capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's proceeds from contributed capital?
Adaptive Biotechnologies (ADPT) reported proceeds from contributed capital of $2.48M in Q1 2026.
What does proceeds from contributed capital mean?
This represents cash inflows received from equity contributions or capital injections from shareholders or other entities. It is a source of financing that does not typically involve the issuance of traditional debt or public equity markets. This metric provides insight into the company's ability to raise capital from existing stakeholders to support operations or growth initiatives.